Lululemon (LULU) Tops Q3 Earnings and Revenue Estimates

Lululemon reported fiscal-quarter results with adjusted EPS of $2.59 versus the Zacks consensus of $2.22 (a 16.7% surprise) and revenue of $2.57 billion, 3.4% above estimates, though EPS declined from $2.87 a year ago; the company has beaten EPS estimates in each of the last four quarters and revenue in three of four. Despite the beat, shares have underperformed sharply—down about 50.9% year-to-date versus the S&P 500’s +17.1%—and near-term price action will hinge on management’s commentary and subsequent earnings-estimate revisions. Consensus expects next-quarter EPS of $4.99 on $3.58 billion in revenue and full-year EPS of $12.91 on $10.95 billion; Zacks assigns a Rank 3 (Hold) given mixed estimate revisions, implying the stock is expected to perform in line with the market absent clearer guidance or revision momentum.

Analysis

Lululemon reported adjusted EPS of $2.59 for the quarter versus the Zacks consensus of $2.22, a 16.67% surprise, and revenue of $2.57 billion, 3.40% above estimates; EPS declined from $2.87 a year ago while revenues rose from $2.4 billion. The company has beaten EPS estimates in each of the last four quarters and revenue in three of four, including a prior-quarter EPS surprise of +9.15%, indicating consistent near-term execution against forecasts.

Shares have underperformed sharply, down about 50.9% year-to-date versus the S&P 500's +17.1%, suggesting market concerns beyond the headline beat. Near-term stock direction will likely hinge on management commentary and whether analyst estimates for the coming quarter ($4.99 EPS on $3.58B revenue) and the fiscal year ($12.91 on $10.95B) are revised materially.

Zacks assigns a Rank #3 (Hold) reflecting mixed estimate-revision trends, while the Textile - Apparel industry ranks in the top 23% of Zacks industries, so industry momentum could be supportive if revisions turn positive. The primary risks are weaker forward guidance or downward estimate revisions that could negate the quarter's beats, so the report should be viewed as creditable execution with uncertain forward visibility rather than a definitive catalyst for renewed outperformance.

Key Decisions for Investors

• Await management commentary on the earnings call and the direction of analyst estimate revisions before initiating new positions
• Monitor consensus next-quarter EPS ($4.99) and full-year EPS ($12.91) and consider trimming or hedging if estimates are meaningfully cut or guidance is lowered
• Given the 50.9% YTD decline and likely volatility, maintain reduced position size or use targeted hedges until post-call clarity emerges
• If post-call revisions and industry momentum turn positive, consider phased accumulation rather than a single large purchase